Company Filing History:
1 out of 989 
1 out of 11 
1 out of 4 Years Active: 2021
Title: Kentaro Sahashi: Innovator in Antisense Oligonucleotide Technology
Introduction
Kentaro Sahashi is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides.
Latest Patents
Sahashi holds a patent titled "Antisense oligonucleotide controlling expression amount of TDP-43 and use thereof." This invention provides a suppression type antisense oligonucleotide targeting TDP-43 mRNA. It contains a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in a nucleotide sequence shown in any of SEQ ID NOs: 2-4. Additionally, it includes a promotion type antisense oligonucleotide targeting TDP-43 mRNA, which contains a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in a nucleotide sequence shown in SEQ ID NO: 5.
Career Highlights
Throughout his career, Kentaro Sahashi has worked with prestigious institutions, including Osaka University and Knc Laboratories Co., Ltd. His work has focused on advancing the understanding and application of antisense technology in medical research.
Collaborations
Sahashi has collaborated with notable colleagues such as Yoshitaka Nagai and Kazuhiro Maeta. Their combined expertise has contributed to the success of various research projects.
Conclusion
Kentaro Sahashi's innovative work in antisense oligonucleotide technology highlights his role as a key figure in molecular biology. His contributions continue to influence the field and pave the way for future advancements.